Older adults with anemia had 66% higher odds of developing dementia, with those with elevated Alzheimer’s disease blood ...

Researchers at WashU Medicine have uncovered new molecular insights into Alzheimer's disease, Parkinson's disease and other ...

Amyloid-beta-targeted monoclonal antibodies probably resulted in little to no difference in cognitive function or in dementia severity.

On the surface, frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are very different neurodegenerative ...

Should you receive a diagnosis of AD, many factors shape how symptoms unfold. The brain, even when under siege, retains an ...

A new study indicates ‘we can identify those that are susceptible to Alzheimer’s disease and give them this peptide [therapy] ...

We used to think of dementia as a disease of old age. But every year, hundreds of thousands of people in their 40s and 50s ...

People with cognitive decline or early-stage dementia saw their symptoms improve when given bespoke treatment plans that ...

Routine gut biopsies predict the risk of developing dementia and related neurodegenerative conditions years before ...

A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...

The study shows anti-inflammatory diets can delay dementia and heart problems by years.

Severe infections are linked to a higher risk for dementia, regardless of whether individuals have frailty, other health issues, or age-related diseases.